T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
BellRing Brands
BRBR
$1.28B
| $36.9M | ﹤0.01% |
1,851,504
-7,456
| -0.4% | -$138K |
|
952
Albany International
AIN
$1.82B
| $36.9M | ﹤0.01% |
628,329
-3,187
| -0.5% | -$172K |
|
|
ELME
953
Elme Communities
ELME
$144M
| $36.6M | ﹤0.01% |
1,647,363
+87,865
| +6% | +$1.96M |
|
954
nVent Electric
NVT
$27.5B
| $36.5M | ﹤0.01% |
1,951,050
-1,504,503
| -44% | -$27.4M |
|
955
Myers Industries
MYE
$1.25B
| $36.5M | ﹤0.01% |
2,509,594
+9,598
| +0.4% | +$119K |
|
|
CCXI
956
DELISTED
ChemoCentryx, Inc.
CCXI
| $36.4M | ﹤0.01% |
632,957
+464,993
| +277% | +$25.3M |
|
|
LVGO
957
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $36.4M | ﹤0.01% |
484,279
+468,768
| +3,022% | +$24.5M |
|
958
Insperity
NSP
$2.05B
| $36.4M | ﹤0.01% |
562,186
-3,211
| -0.6% | -$161K |
|
|
CCF
959
DELISTED
Chase Corporation
CCF
| $36.4M | ﹤0.01% |
354,736
-1,620
| -0.5% | -$151K |
|
960
Texas Capital Bancshares
TCBI
$4.38B
| $36.3M | ﹤0.01% |
1,175,205
-245,131
| -17% | -$6.86M |
|
961
Sprott Physical Gold
PHYS
$15.7B
| $36.2M | ﹤0.01% |
2,529,750
+2,069,250
| +449% | +$28.5M |
|
962
Murphy USA
MUSA
$10.4B
| $36.2M | ﹤0.01% |
321,411
-23,123
| -7% | -$2.53M |
|
963
Legend Biotech
LEGN
$3.93B
| $36.1M | ﹤0.01% |
+849,017
| New | +$33.2M |
|
964
Ameriprise Financial
AMP
$50.4B
| $36M | ﹤0.01% |
240,123
-127,046
| -35% | -$16.3M |
|
965
Quanterix
QTRX
$135M
| $36M | ﹤0.01% |
1,313,573
-73,751
| -5% | -$1.86M |
|
966
Lennar Class A
LEN
$21.1B
| $35.9M | ﹤0.01% |
602,592
-42,694
| -7% | -$2.18M |
|
967
Atkore
ATKR
$3.17B
| $35.4M | ﹤0.01% |
1,294,608
-2,895
| -0.2% | -$71.6K |
|
968
Royal Caribbean
RCL
$82.9B
| $35.2M | ﹤0.01% |
699,877
-1,128,401
| -62% | -$51.1M |
|
969
SPS Commerce
SPSC
$2.86B
| $35.1M | ﹤0.01% |
467,730
+383,042
| +452% | +$23.3M |
|
|
HAYN
970
DELISTED
Haynes International, Inc.
HAYN
| $35.1M | ﹤0.01% |
1,503,508
+12,931
| +0.9% | +$288K |
|
971
Steris
STE
$23B
| $34.9M | ﹤0.01% |
227,514
-38,365
| -14% | -$5.84M |
|
972
Meritage Homes
MTH
$4.8B
| $34.9M | ﹤0.01% |
917,212
+794,764
| +649% | +$23.5M |
|
973
Encompass Health
EHC
$12.2B
| $34.9M | ﹤0.01% |
708,037
-99,073
| -12% | -$5.35M |
|
|
TBIO
974
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $34.8M | ﹤0.01% |
1,942,373
+1,785,309
| +1,137% | +$26.9M |
|
975
10x Genomics
TXG
$7.58B
| $34.8M | ﹤0.01% |
389,510
+44,616
| +13% | +$3.48M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.